The problem. A finished GWAS gives significant variants, but most sit in noncoding regions and none come labeled with a gene or a mechanism. Pulling together the many resources needed to interpret them, linkage structure, effects on gene expression, chromatin state, and gene-set enrichment, meant stitching together separate tools and databases by hand for every study.

The idea. FUMA is a web platform that automates that interpretation. Its first stage groups the associated variants into independent loci and annotates each with predicted effects, expression-QTL links, and chromatin information, then nominates candidate genes. Its second stage takes the prioritized genes and tests them for enrichment in pathways and tissues, running a gene-level association step along the way. The point is integration: many annotation sources joined to the association result in one reproducible pass.

Why it matters. This is the last mile of a GWAS, the move from a statistical hit to a biological hypothesis, and it leans on the same annotation layer I read about for variant calling, VEP and the databases behind it, reused at population scale. It closes the arc of this batch: call variants, associate them, fine-map and colocalize, then annotate the survivors into genes.

Verdict. A widely used interpretation platform that saved the field a lot of manual joining. Read it as the annotation and prioritization end of the GWAS pipeline.